Stock of the Day for November 6, 2024

McKesson Stock Report

McKesson
MCK 90-day performance NYSE:MCK McKesson
Current Price
$711.32
-8.48 (-1.18%)
(As of 09/12/2025 03:59 PM ET)
30 Day Performance
5.72%
  
 
90 Day Performance
-1.14%
  
  
1 Year Performance
37.11%
  
 
Market Capitalization
$88.47B
P/E Ratio
28.36
Dividend Yield
0.46%

About McKesson

McKesson Corporation, founded in 1833 as John McKesson & Co., is one of the oldest and largest healthcare services and information technology companies in the United States. Headquartered in Irving, Texas, McKesson began as a regional pharmaceutical wholesaler in New York City and over nearly two centuries has grown into a global enterprise serving multiple facets of the healthcare industry.

At the core of McKesson’s operations is its Pharmaceutical Distribution segment, which supplies branded, generic and over-the-counter medications, vaccines and biopharmaceutical therapies to retail pharmacies, hospitals, physician offices and alternate-site care providers. The company also distributes medical-surgical supplies, laboratory products and a broad portfolio of infusion services and equipment, helping to streamline the supply chain and reduce costs for its customers.

Complementing distribution is McKesson’s Technology Solutions segment, offering software and automation solutions designed to improve clinical workflow, enhance care coordination and support revenue management. These technologies include pharmacy automation, electronic health record (EHR) systems, medication management software and analytics platforms. McKesson’s services extend to specialty practices, oncology providers, home health agencies and long-term care facilities.

With operations spanning North America, Europe and select international markets, McKesson serves a diverse customer base that ranges from independent community pharmacies to large health systems. Under the leadership of President and Chief Executive Officer Brian S. Tyler, the company continues to pursue strategic partnerships and acquisitions aimed at expanding its distribution footprint, enhancing its technology offerings and ultimately supporting more efficient, patient-centered care worldwide.

MCK Company Calendar

JUN. 2, 2025
Ex-Dividend for 7/1 Dividend
JUL. 1, 2025
Dividend Payable
AUG. 6, 2025
Last Earnings
SEP. 2, 2025
Ex-Dividend for 10/1 Dividend
SEP. 14, 2025
Today
OCT. 1, 2025
Dividend Payable
NOV. 5, 2025
Next Earnings (Estimated)
MAR. 31, 2026
Fiscal Year End

Recent McKesson News

Swedbank AB Cuts Stock Holdings in McKesson Corporation $MCK
McKesson Corporation $MCK Shares Sold by Howe & Rusling Inc.
First Hawaiian Bank Buys 1,980 Shares of McKesson Corporation $MCK
Strs Ohio Buys Shares of 183,476 McKesson Corporation $MCK
Ellsworth Advisors LLC Purchases Shares of 7,962 McKesson Corporation $MCK
Advisors Capital Management LLC Grows Position in McKesson Corporation $MCK
WBI Investments LLC Takes Position in McKesson Corporation $MCK
McKesson Corporation $MCK Stock Holdings Lifted by Focus Partners Wealth
Plato Investment Management Ltd Trims Holdings in McKesson Corporation $MCK
This report was written by MarketBeat.com on September 14, 2025. This report first appeared on MarketBeat.com.